Compounds > arabinofuranosyluracil

arabinofuranosyluracil and tetrahydrouridine

arabinofuranosyluracil has been researched along with tetrahydrouridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engle, KK; Higuchi, T; Liversidge, GG; Nishihata, T1
Avramis, VI; Powell, W1
Bunch, C; Grahame-Smith, DG; Harris, AL; Potter, CG1

Other Studies

3 other study(ies) available for arabinofuranosyluracil and tetrahydrouridine

ArticleYear
Enhanced serum concentrations of Ara-C using suppositories containing tetrahydrouridine as a deamination inhibitor of Ara-C.
    The Journal of pharmacy and pharmacology, 1986, Volume: 38, Issue:3

    Topics: Animals; Arabinofuranosyluracil; Biological Availability; Cytarabine; Deamination; Dogs; Kinetics; Salicylates; Salicylic Acid; Suppositories; Tetrahydrouridine; Uridine

1986
Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Cancer investigation, 1987, Volume: 5, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Cytarabine; Deamination; Leukemia L1210; Male; Mice; Tetrahydrouridine; Time Factors; Uridine

1987
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
    Clinical science (London, England : 1979), 1981, Volume: 60, Issue:2

    Topics: Adult; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Bone Marrow; Cells, Cultured; Cytarabine; Deamination; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia, Myeloid, Acute; Tetrahydrouridine

1981